---
category: news
title: "Lantern Pharma Reports First Quarter 2022 Financial Results and Operational Highlights"
excerpt: "DALLAS, May 3, 2022 /PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR Â® artificial intelligence (\"A.I ... the potential of combination therapy for these two agents."
publishedDateTime: 2022-05-03T23:30:00Z
originalUrl: "https://www.kron4.com/business/press-releases/cision/20220503DA44966/lantern-pharma-reports-first-quarter-2022-financial-results-and-operational-highlights/"
webUrl: "https://www.kron4.com/business/press-releases/cision/20220503DA44966/lantern-pharma-reports-first-quarter-2022-financial-results-and-operational-highlights/"
type: article
quality: 16
heat: -1
published: false

provider:
  name: KRON4
  domain: kron4.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg"
    width: 400
    height: 296
    isCached: true

related:
  - title: "Perimeter Medical Imaging AI Reports 2021 Financial Results and Provides Corporate Update"
    excerpt: "Perimeter officially progresses to commercial stage with its first S-Series OCT installation. Clinical development of B-Series OCT with ImgAssist AI advances into late-stage validation activities with the initiation of a multi-center, randomized ..."
    publishedDateTime: 2022-05-02T21:21:00Z
    webUrl: "https://www.benzinga.com/pressreleases/22/05/b26949844/perimeter-medical-imaging-ai-reports-2021-financial-results-and-provides-corporate-update"
    ampWebUrl: "https://www.benzinga.com/amp/content/26949844"
    cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/26949844"
    type: article
    provider:
      name: Benzinga.com
      domain: benzinga.com
    quality: 48
    images:
      - url: "https://www.benzinga.com/next-assets/images/schema-image-default.png"
        width: 1043
        height: 1043
        isCached: true

secured: "vY/Bb0ONq+Ty9COciva4vGu7tsig2gCoL/U4GBGPL3WQSy8oN4L7W/qQNIDF29dhKpAksU78Kak1LCy0k/jQ4CkgvYbBw7dB6vJlb/+m/Gov+rv/CipjH3KxFNVZlkVXsIRgWwMyS4l7hoJvUsnSAwlkxDFi0Q5pSdRWwAvR3qP8jMpVAJpbvKZcaKSqVWjPzrJWz6aA26Gwb5qVnSQfH7oHszvYBOitk//OlLr3seye6FHdPDn0UybW0L2xOd0FMpfNdarNAdZQFAbN9fYhtH8YIN8YjPKO0bpssD45TjnjE84xHGxlWUVf1V+j5a4pw8P63so94ZibRBR5mf/1lEIHjZK3k4tTzUaqIqU9At8=;WEM3R0GzflkltLvZrVd3lA=="
---

